BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11230745)

  • 1. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.
    Fracanzani AL; Conte D; Fraquelli M; Taioli E; Mattioli M; Losco A; Fargion S
    Hepatology; 2001 Mar; 33(3):647-51. PubMed ID: 11230745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives.
    Elmberg M; Hultcrantz R; Ebrahim F; Olsson S; Lindgren S; Lööf L; Stål P; Wallerstedt S; Almer S; Sandberg-Gertzén H; Ekbom A; Askling J
    Gastroenterology; 2009 Oct; 137(4):1301-9. PubMed ID: 19622361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases.
    Bradbear RA; Bain C; Siskind V; Schofield FD; Webb S; Axelsen EM; Halliday JW; Bassett ML; Powell LW
    J Natl Cancer Inst; 1985 Jul; 75(1):81-4. PubMed ID: 2989605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.
    Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ
    Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis.
    Crawford DH; Fletcher LM; Hubscher SG; Stuart KA; Gane E; Angus PW; Jeffrey GP; McCaughan GW; Kerlin P; Powell LW; Elias EE
    Hepatology; 2004 Jun; 39(6):1655-62. PubMed ID: 15185307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
    Geier D; Hebert B; Potti A
    Anticancer Res; 2002; 22(6B):3797-9. PubMed ID: 12552996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
    Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
    von Delius S; Lersch C; Schulte-Frohlinde E; Fend F; Dobritz M; Schmid RM; Eckel F
    Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of liver transplantation in hereditary hemochromatosis.
    Dar FS; Faraj W; Zaman MB; Bartlett A; Bomford A; O'Sullivan A; O'Grady J; Heneghan M; Rela M; Heaton ND
    Transpl Int; 2009 Jul; 22(7):717-24. PubMed ID: 19490544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
    Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
    Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
    Di Costanzo GG; De Luca M; Tritto G; Lampasi F; Addario L; Lanza AG; Tartaglione MT; Picciotto FP; Ascione A
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):674-9. PubMed ID: 18679071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.
    Hamada H; Yatsuhashi H; Yano K; Daikoku M; Arisawa K; Inoue O; Koga M; Nakata K; Eguchi K; Yano M
    Cancer; 2002 Jul; 95(2):331-9. PubMed ID: 12124834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron in the pathogenesis of hepatocellular carcinoma.
    Fargion S; Piperno A; Fracanzani AL; Cappellini MD; Romano R; Fiorelli G
    Ital J Gastroenterol; 1991 Dec; 23(9):584-8. PubMed ID: 1662094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter?
    Thakur V; Guptan RC; Malhotra V; Basir SF; Sarin SK
    J Assoc Physicians India; 2002 Nov; 50():1386-94. PubMed ID: 12583467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEN virus infection and the risk of hepatocellular carcinoma: a case-control study.
    Tangkijvanich P; Theamboonlers A; Sriponthong M; Kullavanijaya P; Poovorawan Y
    Am J Gastroenterol; 2003 Nov; 98(11):2500-4. PubMed ID: 14638355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
    Jee SH; Ohrr H; Sull JW; Samet JM
    J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.